收藏切换
Quality evaluation of compound Chinese medicines as related to clinical efficacy
收藏切换
PDF
Jiang-lan LONG1, 2, Ai-ting WANG1, 2, Zhi-rui YANG1, 2, Ke-jun DENG3, Hao LIN4, *, Dan YAN1, 2, *
Acta Pharmaceutica Sinica | 2021, 56(12) : 3414 - 3420
Less
收藏切换
Acta Pharmaceutica Sinica | 2021, 56(12): 3414-3420
Reviews
Quality evaluation of compound Chinese medicines as related to clinical efficacy
Full
Jiang-lan LONG1, 2, Ai-ting WANG1, 2, Zhi-rui YANG1, 2, Ke-jun DENG3, Hao LIN4, *, Dan YAN1, 2, *
Affiliations
  • 1. Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
  • 2. Beijing Institute of Clinical Pharmacy, Beijing 100050, China
  • 3. School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu 610054, China
  • 4. Center for Informational Biology, University of Electronic Science and Technology of China, Chengdu 610054, China
Published: 2021-12-12 doi: 10.16438/j.0513-4870.2021-1003
Outline
收藏切换

The quality evaluation of compound Chinese medicines is an important but challenging issue in this research field, which has been paid much controversial due to the constrained association with clinical efficacy. Developing a methodology for quality evaluation of compound Chinese medicines related to clinical efficacy is an important measure in research on Chinese material medica quality to ensure clinical effectiveness and safety. Therefore, based on the research concept that "originating from clinic-testing in experiment-returning to clinic", and taking Xiaoke prescription as an example, the characteristic information of metabolome, proteome and microbiome are discussed from the clinical aspect, and the integrated markers associated with clinical efficacy constructed with artificial intelligence technology. Taking the integrated markers as the link and indication are connecting the clinical and basic, the main pharmacodynamic substances and key targets of Xiaoke prescription that are related to clinical efficacy are explained. Clinical samples are used for validation. Based on the main pharmacodynamic substances and key targets, methods and key technologies for chemical and biological evaluation of the quality of Xiaoke prescription are established, providing a methodology for quality evaluation of compound Chinese medicines, including clinical efficacy response indicators (related to clinic), main pharmacodynamic substances (chemical evaluation), and key targets (biological evaluation), to provide new ideas and methods for improving the quality evaluation of compound Chinese medicines.

compound Chinese medicines  /  Xiaoke prescription  /  quality evaluation  /  related to clinical efficacy  /  integrated marker  /  methodology
Jiang-lan LONG, Ai-ting WANG, Zhi-rui YANG, Ke-jun DENG, Hao LIN, Dan YAN. Quality evaluation of compound Chinese medicines as related to clinical efficacy[J]. Acta Pharmaceutica Sinica, 2021 , 56 (12) : 3414 -3420 . DOI: 10.16438/j.0513-4870.2021-1003
Year 2021 volume 56 Issue 12
PDF
176
72
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2021-1003
  • Receive Date:2021-07-09
  • Online Date:2025-12-18
  • Published:2021-12-12
Article Data
Affiliations
History
  • Received:2021-07-09
  • Revised:2021-10-11
Funding
Affiliations
    1. Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
    2. Beijing Institute of Clinical Pharmacy, Beijing 100050, China
    3. School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu 610054, China
    4. Center for Informational Biology, University of Electronic Science and Technology of China, Chengdu 610054, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2021-1003
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT